Seeking Alpha

Synta Pharmaceuticals jumps on publication of ganetespib results

  • Synta Pharmaceuticals (SNTA +4.2%) moves higher in early trading.
  • The shares are likely getting a lift from news that collaborators at Johns Hopkins and Duke's Dana-Farber Cancer Institute have separately published results which the company says "demonstrate the ability of ganetespib to down-regulate a number of key proteins involved in tumor growth and metastasis." (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|